Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Omega-6 fats in certain cells boost male hormone production.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Monkeys with hair loss during pregnancy showed higher stress hormone levels and invested differently in their offspring.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Policosanol helps treat hair loss by balancing hormones and supporting hair growth.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Hormones cause hair loss by affecting cell growth and weakening cell attraction.

Hormone levels in hair vary across the head, with the highest concentration of a key hormone linked to hair loss at the top.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Many transgender men on testosterone therapy experience hair loss.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Short photoperiods improve cashmere growth and quality in goats by changing hormone levels and gene expression.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Hormone therapy might help improve women's appearance as they age.

A woman developed male characteristics after using unregulated hormone therapy.